Development of a colloidal gold immunochromatographic assay utilizing dual-antibody sandwich method for detecting Orientia tsutsugamushi

Development of a colloidal gold immunochromatographic assay utilizing dual-antibody sandwich method for detecting Orientia tsutsugamushi

A colloidal gold immunochromatographic assay (ICA) based on a dual-antibody sandwich method was developed for the rapid and convenient detection of Orientia tsutsugamushi (O. tsutsugamushi) antigens in the early stages of infection. Monoclonal antibodies designed as 5B3 targeting the conserved regio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qingyu Lu, Shiyin Yu, Sibo Wang, Min Cao, Liuxin Li, Miao Xin, Weilong Tan, Yong Qi, Yichen Lu, Xiaohui Xiong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Microbiology
Subjects:	O. tsutsugamushi monoclonal antibody polyclonal antibody immunochromatography colloidal gold
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1521015/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preparation and application evaluation of monoclonal antibodies against Monkeypox virus A29 protein
by: Ai Xiangjun, et al.
Published: (2025-01-01)

A Novel Strain of <i>Orientia tsutsugamushi</i> Detected from Chiggers (Acari: Trombiculidae) on Wild Rodents
by: Hak Seon Lee, et al.
Published: (2025-01-01)

Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
by: Stefan Dübel
Published: (2024-12-01)

Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01)

Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge
by: M. Biddle, et al.
Published: (2024-12-01)

Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies
by: Ugochi Ebinama, et al.
Published: (2025-01-01)

Introduction to Modern Colloid Science /
by: Hunter, Robert J.
Published: (1993)

How to use monoclonal antibody-based therapy in ALL
by: Erica Brivio, et al.
Published: (2025-06-01)

Characterization of two neutralizing monoclonal antibodies with conformational epitopes against porcine deltacoronavirus
by: Wan Lu, et al.
Published: (2025-01-01)

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
by: Aimee E. Mattei, et al.
Published: (2024-12-01)

A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies
by: Shen Luo, et al.
Published: (2024-12-01)

Antibacterial activity improvement in a point mutant K45E of the pepper defensin J1-1
by: Gilberto Andrés Muñoz-Pérez, et al.
Published: (2024-10-01)

Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps
by: Shaun J. Kilty, et al.
Published: (2022-04-01)

Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens
by: Pedro Cruz, et al.
Published: (2024-12-01)

Learn from international recommendations and experiences of countries that have successfully implemented monoclonal antibody prophylaxis for prevention of RSV infection
by: Sara Manti, et al.
Published: (2025-02-01)

BINARY HARD-SPHERE COLLOID-DROPLET MIXTURES WITH THE PYRITE-TYPE STRUCTURE
by: Minh Tu Vu, et al.
Published: (2023-03-01)

Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review
by: Hongxia Wang, et al.
Published: (2025-01-01)

Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
by: Mingya Cao, et al.
Published: (2025-01-01)

The potential role of nanobodies in asthma therapy
by: Baraa Khalid Salah Al-Sheakly, et al.
Published: (2025-01-01)

The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, parallel-controlled clinical study
by: Yin Yin, et al.
Published: (2025-01-01)

Spatiotemporal regulation of alginate sub-structures at multiple scales revealed by monoclonal antibodies
by: Catherine T. Jones, et al.
Published: (2025-06-01)

Development of an Enzyme-Linked Immunosorbent Assay Based on a Monoclonal Antibody for the Rapid Detection of Citrinin in Wine
by: Xingdong Yang, et al.
Published: (2024-12-01)

Preparation and application of porcine broadly neutralizing monoclonal antibodies in an immunoassay for efficiently detecting neutralizing antibodies against foot-and-mouth disease virus serotype O
by: Yimei Cao, et al.
Published: (2025-02-01)

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
by: Alberto L. Horenstein, et al.
Published: (2025-02-01)

Cost-savings and health impact of strategies for prevention of Respiratory Syncytial Virus with nirsevimab in Chile based on the integrated analysis of 2019–2023 national databases: A retrospective study
by: Denis Sauré, et al.
Published: (2025-04-01)

New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its receptor
by: K. Ryliškienė, et al.
Published: (2019-12-01)

Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era
by: Austin Heffernan, et al.
Published: (2022-05-01)

Targeting RGMb interactions: Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple ligand bindings
by: Maria Meira, et al.
Published: (2024-12-01)

Current Advances and Future Prospects in Cancer Immunotherapeutics
by: Zeynep DEDE, et al.
Published: (2023-03-01)

Predicting the clinical subcutaneous absorption rate constant of monoclonal antibodies using only the primary sequence: a machine learning approach
by: Ronghua Bei, et al.
Published: (2024-12-01)

Navigating Recent Changes in Dosing Information: Dynamics of FDA‐Approved Monoclonal Antibodies in Post‐Marketing Realities
by: Nai Lee, et al.
Published: (2025-01-01)

Monoclonal antibodies to treat COVID-19 in rheumatoid arthritis: A case report and a clinical appraisal of selected drug trials
by: Arvind Chopra
Published: (2022-01-01)

No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy
by: Konrad van der Zwet, et al.
Published: (2025-01-01)

Rare Neurological Manifestations of Scrub Typhus: Case Series from a Tertiary Care Centre in Kerala, India
by: NR Salini, et al.
Published: (2025-01-01)

Clinical symptoms and surgical outcome of colloid cysts of the third ventricle: A multicenter retrospective study
by: V.M. Butenschoen, et al.
Published: (2025-01-01)

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
by: Ana C. Montagud, et al.
Published: (2025-01-01)

Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity
by: Dafei Chai, et al.
Published: (2025-01-01)

Erenumab effectiveness and safety: comparison of real-life data and clinical trial results
by: Austėja Dapkutė, et al.
Published: (2021-12-01)

Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats
by: Axelle Amen, et al.
Published: (2025-01-01)

Quantifying LAGA mutated mouse IgG2a monoclonal antibody with a rapid pepsin digestion enabled immunoaffinity LC/MS/MS assay
by: Linlin Dong, et al.
Published: (2024-12-01)